Carruthers R Michael

Carruthers R Michael is listed in filings as Director at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR), Edgewise Therapeutics, Inc. (EWTX), and Elevation Oncology, Inc. (ELEV). The current snapshot covers public activity from Jun 17, 2024 to Jun 8, 2026. Reported amounts are shown as $32.9K to $37.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.